Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 4/20 | 0.65 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.56 |
| ▸ | FLT1 | P17948 | 1/20 | 0.56 |
| ▸ | PARP1 | P09874 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 6/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.46 |
| ▸ | DHODH | Q02127 | 2/20 | 0.45 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.45 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21017806 | 0.80 | CHEK2 (0.72) | CHEK2FGFR1FLT1ACHEHRH4 | |
| SCHEMBL217151 | 0.80 | CHEK2 (0.57) | CHEK2ACHEPDE3BPDE3A | |
| SCHEMBL21018072 | 0.79 | CHEK2 (0.74) | CHEK2FGFR1FLT1ACHEHRH4 | |
| SCHEMBL215872 | 0.79 | CHEK2 (0.55) | CHEK2FGFR1FLT1PARP1ACHE | |
| SCHEMBL215873 | 0.78 | CHEK2 (0.53) | CHEK2FGFR1FLT1PARP1HRH3 | |
| SCHEMBL21018394 | 0.74 | ACHE (0.81) | CHEK2FGFR1FLT1PARP1ACHE | |
| SCHEMBL21018067 | 0.74 | ACHE (0.81) | CHEK2FGFR1FLT1PARP1ACHE | |
| SCHEMBL1553016 | 0.73 | CHEK2 (0.86) | CHEK2PARP1ACHEDHODH | |
| SCHEMBL215077 | 0.72 | CHEK2 (0.46) | CHEK2FGFR1FLT1PARP1ACHE | |
| SCHEMBL21018393 | 0.72 | ACHE (0.72) | CHEK2FGFR1FLT1PARP1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088767-B2 | JAK-2 modulators and methods of use | EXELIXIS, INC. (US) | 2012-01-03 | — | — | US | disclosed |